Although pentolinium tartrate is widely used in the treatment of hypertension, there are no reports available regarding some of its cardiovascular effects and its influence on water and electrolyte excretion. The results of the present study indicate that this drug is of value in reducing the mean arterial blood pressure in hypertensive patients. However, the data also indicate the necessity for caution in the use of this agent and the need for a continuing search for newer agents in the treatment of this disease.
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P ENTOLINIUM tartrate (Ansolysen), a ganglionic-blocking agent, has been widely used in the treatment of human hypertension. '-3 Although adequate clinical information is available in these studies, there are no available reports describing the effects of this agent on systemic and renal hemodynamics and metabolism, as well as on water and electrolyte excretion. The following investigation reports the acute responses in these functions following the intravenous administration of this drug to hypertensive patients.
METHODS
Ten patients with arterial hypertension and 1 normotensive subject, obtained from the medical wards of the University Hospitals, were studied in the supine position in a fasting state. Complete data and diagnoses are given in tables 1-4. Systemic hemodynamics alone were determined in 3 
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. pressure, noted above, was accompanied by a significant reduction in glomerular filtration rate and in effective renal plasma flow, such that the filtration fraction decreased significantly. Neither total renal blood flow nor the arterial-renal venous oxygen difference changed significantly and although both functions were in a downward direction, their product, the renal oxygen consumption, was not significantly reduced. Furthermore, the fall in renal Qo2 was out of proportion to the decline in TmPAH, so that the ratio Qo2/Tm was also reduced. Although renal peripheral resistance varied widely, there was no significant change from the control values.
Water and Electrolyte Response. (Table 3 .) Within 15 minutes following the administration of pentolinium tartrate a significant antidiuresis occurred and continued to increase through the duration of the experiments. During the first 15 minutes the associated decreases in sodium, potassium, and chloride excretion exceeded the fall in urine flow, so that, as seen in patient A.P. (table 4) , urinary osmolarity fell. However, with the passage of time, the decrease in urine flow exceeded the significant reductions in electrolytes and chloride excretion with a resultant rise in the osmolarity of the urine. Furthermore, declines in the excretion rates of sodium and chloride exceeded those of potassium. The result of the retention of water was reflected in a significant fall in hematocrit.
Calculation of the excretion of buffer base according to the method of Singer and associates7 showed a marked reduction. In addition, urinary pH decreased and the pH of whole blood and serum increased, the latter changes being brought about by a rise in whole blood buffer base and serum bicarbonate.
DISCUSSION Systemic Hemodynamic and Metabolic
Changes. The alterations found in these functions are similar to those previously described by Crumpton and co-workers8 for hexamethonium, a closely allied ganglionicblocking agent. As in the case of the latter agent, it was noted that the fall in mean arterial blood pressure is accounted for largely H50PIH'YRTENSIVE PATIENTS AND PENTOLINIUM TARTRATE on the basis of a fall in cardiac output, since total peripheral resistance remained essentially unaltered. The observation that skin temperatures rise following ganglionic-blocking agents9 need not conflict with the latter finding, since total peripheral resistance includes not only skin but all other vascular beds (e.g., muscle). The reciprocal changes in skin and muscle blood flow are well established.10 Furthermore, as in this study, the investigation of an isolated vascular bed such as the kidney revealed no significant change in its resistance, although the mean values were in an upward direction.
The fall in cardiac output was probably related to a decreased venous return as evidenced by significant reductions in right atrial and right ventricular end-diastolic pressures. Such alterations suggest either generalized venous pooling, or the "trapping" of blood within specific vascular beds (e.g., splanchnic). Since Cominsky and associates" have found an increase in splanchnic blood volume following hexamethonium, the latter explanation is favored.
Renal Hemodynamic and Metabolic Changes. These changes are similar to those described by Miles and Moyer'2 for hexamethonium. Furthermore, they are in keeping with the observed systemic hemodynamic and metabolic changes. Thus, the change in over-all renal peripheral resistance was in an upward direction similar to that of the total peripheral resistance although neither function showed a significant change. This change in renal resistance associated with a fall in filtration fraction suggests simultaneous afferent arteriolar constriction and efferent arteriolar dilatation. The decline in renal oxygen consumption conforms with the decrease in total body oxygen consumption. The fall in QO2/TmpAH is a further reflection of the marked action of this agent on tissue oxygen consumption.
lVater and Electrolyte Responses. The decreased excretion of water and electrolytes was rapid in onset (usually within 15 min.) and progressive, so that the greatest reductions were noted at the end of the experiment (60 min. after administration of the drug). Our data do not permit us to say whether this occurred on a hemodynamic or hormonal basis.
It might be argued that such changes were the result of a decreased urine flow and related to urine collection. However, against such a concept are the following points: (a) the systemic alterations (hematocrit, blood pH, whole blood buffer base, etc.) are in keeping with the observed changes in electrolyte and water excretion; (b) the various hemodynamic and electrolyte alterations do not change to the same degree at the same time, as might be expected were this related to urine collection alone; (c) the changes in urinary osmolarity and in the calculated values for electrolytes suggest that tubular as well as hemodynamic factors are responsible for these findings; (d) chronic metabolic studies in hypertensive patients receiving pentolinium indicate that the retention of sodium and water may be sufficient to produce congestive heart failure in patients with a low cardiac reserve. '3 Finally, these data should not be interpreted to indicate that the use of pentolinium is contraindicated in hypertensive and cardiac patients because this agent has been shown to be of value by Ellestad and Olson14 in the treatment of acute pulmonary edema, where venous pooling and a decrease in right and left ventricular work are highly desirable and, as shown by previous investigators,'-' including our own hypertensive clinic, this drug is capable of reducing blood pressure, thereby causing a cessation of progression or even a regression of some of the objective manifestations in other vascular beds, and perhaps even of increased longevity.
However, these results are presented for the following purposes: (a) to explain, on an acute basis, and possibly on a chronic basis," the mechanisms whereby pentolinium produces a fall in mean arterial blood pressure; (b) to illustrate some of the side effects, particularly with regard to water and electrolyte excretion, which are associated with this reduction in blood pressure, so that these factors may be considered in the course of antihypertensive therapy; (c) to demonstrate that if, according to our present knowledge, the mechanism of CROSLEY AND CO-WORKERS essential hypertension is an increased total peripheral resistance with no change in cardiac output, there is a necessity for continuing our search for newer antihypertensive agents that will bring about a decline in mean arterial blood pressure by means of a reduction in total peripheral resistance rather than at the expense of cardiac output.
SUMMARY
In an acute study, pentolinium tartrate, in a dosage of 2.0 to 2.5 mg. intravenously, produced a reduction in mean arterial blood pressure that was directly related to a fall in cardiac output with little or no change in peripheral vascular resistance.
Associated with these changes, renal filtration fraction fell significantly and was accompanied by significant reductions in water, sodium, potassium, and chloride excretions.
The changes in water and electrolyte excretion appeared to be related to both hemodynamic and renal tubular factors.
These data indicate that pentolinium tartrate is of value in the reduction of mean arterial blood pressure in hypertensive patients. However 473 of these patients and provided information on the outcome of untreated syphilis, which has formed the basis for prognostic statements on syphilis for more than 25 years. This material has recently been restudied by Gjestland, utilizing modern epidemiologic methods, and published in monograph form. The present paper reviews and appraises Gjestland's study, presents some of the details of the planning and execution of this large-scale investigation, provides a brief resume of the results, and emphasizes the significance of this investigation for the natural history of chronic disease.
The remarkable degree of success in obtaining significant information on approximately 80 per cent of the study group was due to the careful planning that preceded the tracing efforts. Clinical secondary relapse occurred in 23.6 per cent of the patients within 5 years of discharge from the hospital, and, of these, approximately one-fourth had multiple episodes. Benign late syphilis occurred in 14 .4 per cent of the males and 16.7 per cent of the females, the majority developing by the fifteenth year after discharge. Cardiovascular syphilis was observed to have developed in 13.6 per cent of males and 7.6 per cent of females, no cases occurring in those infected before the age of 15 . Neurosyphilis developed in patients who were infected before the age of 15 but not in males infected after the age of 40. In neurosyphilis there was a 2 to 1 ratio of males to females (males 9.4 per cent and females 5.0 per cent). The mortality from syphilis among males was twice that of females, but in neither sex was it an important cause of death. No evidence was found to support the idea of the prognostic importance of either clinical secondary relapse or benign late syphilis.
The best definition of spontaneous cure is too rigid to permit quantitative evaluation. More practical is a consideration of the extent of disability during the lifetime of the persons involved. It was estimated that between 60 and 70 out of every 100 of these patients went through life with a minimum of inconvenience despite no treatment for early syphilis. This gives no encouragement to withhold treatment because the final outcome in any individual cannot be predicted; also, syphilis is still a transmissible disease when untreated and can cause serious difficulties among 30 to 40 out of each 100 untreated cases. This is probably the most comprehensive study of untreated syphilis that has yet been made, and the great mass of data that has been collected will provide the basis for additional contributions to our knowledge of syphilitic infection.
